Filing Flows › Upstream Bio (UPB) › Next earnings date
Upstream Bio (UPB) earnings on Nov 10, 2026: what to expect
Upstream Bio (UPB) is expected to report earnings on Nov 10, 2026 (estimated), in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.73 (−$0.88 to −$0.52, 8 estimates) on revenue of $480K, against −$0.63 and $683K a year ago. It beat the EPS estimate in 75% of the quarters on record; Filing Flows' model gives it a 75% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.63 on revenue of $928K, against the analysts' −$0.73.
The last report
Upstream Bio reported revenue of $773K for the second quarter 2026 (-18% Y/Y), net loss $39.7M. How it makes money → · Every quarter →
Upstream Bio's latest quarter
Upstream Bio, Q2 2026: revenue $773K (-18% year over year), net loss $39.7M, operating cash flow −$35.6M. The chart follows the revenue to costs, profit and cash.
Questions
When does UPB report earnings?
Upstream Bio is expected to report on Nov 10, 2026 (estimated).
What are analysts expecting from Upstream Bio?
EPS of −$0.73 and revenue of $480K for the quarter.
Does Upstream Bio usually beat earnings?
It beat the consensus EPS estimate in 75% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.